학술논문

Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies
Document Type
Journal
Source
ACS MEDICINAL CHEMISTRY LETTERS; JUN 7 2022, 7p.
Subject
Language
English
ISSN
19485875